NCT06525181 AI as an Aid for Weekly Symptom Intake in Radiotherapy
| NCT ID | NCT06525181 |
| Status | Recruiting |
| Phase | — |
| Sponsor | jaide |
| Condition | Radiotherapy Side Effect |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-07-22 |
| Primary Completion | 2024-11-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The study investigates the use of artificial intelligence (AI) and large language models (LLMs) to enhance the efficiency and accuracy of weekly treatment consultations (OTVs) in radiotherapy. It hypothesizes that an AI-enabled symptom summary tool will match traditional medical review methods in accuracy while saving time. The study includes patients undergoing pelvic radiotherapy and excludes those with pelvic reirradiation or who have undergone surgery. Patients will receive both standard and AI-assisted weekly consultations, with AI summaries generated using the OpenAI GPT-4 API. Blinded oncologists will compare the accuracy and quality of the AI-generated and doctor-generated summaries, while patients and doctors will rate these summaries. The primary objective is to evaluate the accuracy and time efficiency of AI-assisted symptom summaries compared to traditional methods.
Eligibility Criteria
Inclusion Criteria: All patients undergoing radiotherapy in the pelvic region. Exclusion Criteria: Cases of pelvic reirradiation or operated cases.